Researchers investigated early pathophysiological mechanisms potentially underlying PASC post-SARS-CoV-2 infection.
SomaLogic, co-founder of acquired company battle in court over unvested stock
Proteomics biotech SomaLogic and the co-founder of a company it bought last year are suing each other in separate court battles playing out in Colorado